Richard Limehouse
Directeur/Bestuurslid bij GeneVentiv Therapeutics, Inc.
Oorsprong van het eerstegraads netwerk van Richard Limehouse
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
GeneVentiv Therapeutics, Inc.
 GeneVentiv Therapeutics, Inc. BiotechnologyHealth Technology GeneVentiv Therapeutics, Inc. is a company that is developing the first gene therapy for patients with hemophilia A or B, with or without inhibitors. The company is based in Raleigh, NC. The company's product, Genv-Hem, produces clotting factor Va, which allows for normal clotting in response to injury. Currently, there are no curative gene therapies available for patients with inhibitors. GeneVentiv Therapeutics was founded by Chengwen Li and the CEO is Damon R Race.
2
| Holding Company | Biotechnology | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Richard Limehouse via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Nabgen, Inc. | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 2 |
Sectoraal
Operationeel
| Director/Board Member | 2 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
| President | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Chengwen Li | 2 |
| Damon R Race | 1 |
- Beurs
- Insiders
- Richard Limehouse
- Bedrijfsconnecties
